Deprescribing and Polypharmacy in an Aging Population

Deprescribing and Polypharmacy in an Aging Population

Elbeddini, Ali

161,20 €(IVA inc.)

Describing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population. Describing and Polypharmacy in an Aging Population helps reduce the harm that can occur with polypharmacy. Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts Identifies barriers and enablers for the implementation of deprescribing programs Develops strategies to address barriers and optimize enablers for deprescribing implementation INDICE: 1. Deprescribing Around the Globe2. Deprescribing in Palliative Patients3. Deprescribing in Alzheimer's Patients4. Guidelines, Algorithms, and Emerging Evidence: Deprescribing as an Essential Part of Prescribing5. Educating Young Professionals: Incorporation of Deprescribing into School Curriculums6. Multidisciplinary Teams are Essential for Deprescribing7. Case Studies: Risks of Polypharmacy and the Impact of Deprescribing on Quality of Life8. Looking to the Future: Artificial Intelligence in Deprescribing9. Challenges of Deprescribing During COVID-1910. Implementation of Deprescribing in Institutions and Future Directions

  • ISBN: 978-0-323-99138-4
  • Editorial: Academic Press
  • Encuadernacion: Rústica
  • Páginas: 350
  • Fecha Publicación: 01/06/2023
  • Nº Volúmenes: 1
  • Idioma: Inglés